Beaconlight Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.3M Buy
+5,946
New +$2.21M 0.81% 29
2020
Q2
Sell
-32,400
Closed -$7.36M 36
2020
Q1
$7.36M Buy
+32,400
New +$8.83M 1.96% 16
2018
Q4
Sell
-32,215
Closed -$8.83M 33
2018
Q3
$8.83M Sell
32,215
-22,435
-41% -$5.82M 2.88% 11
2018
Q2
$13M Buy
+54,650
New +$12.7M 4.87% 8
2018
Q1
Sell
-17,468
Closed -$3.93M 21
2017
Q4
$3.93M Buy
17,468
+9,268
+113% +$1.97M 1.44% 18
2017
Q3
$1.56M Sell
8,200
-15,600
-66% -$2.97M 0.82% 16
2017
Q2
$4.48M Sell
23,800
-13,900
-37% -$2.5M 3.6% 9
2017
Q1
$6.24M Buy
+37,700
New +$6M 3.96% 11

Other funds holding ELV

Beaconlight Capital's ELV Position: Q2 2026 in Review

Beaconlight Capital opened a new position in Elevance Health (ELV) in Q2 2026: 5,946 shares worth $2.3M. The stake represents 0.81% of the portfolio and ranks #29 among its holdings. This is a return to the name: Beaconlight Capital previously reported a position in ELV as recently as Q1 2020.

Beaconlight Capital first reported a position in ELV in Q1 2017 and has held it in 8 quarters since. The position peaked at $13M in Q2 2018. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Beaconlight Capital held 5,946 shares of Elevance Health worth $2.3M as of Q2 2026.
  • Elevance Health was a new Beaconlight Capital position in Q2 2026.
  • Elevance Health made up 0.81% of Beaconlight Capital's portfolio in Q2 2026, its #29 holding.
  • Beaconlight Capital first reported a position in Elevance Health in Q1 2017 and has held it in 8 quarters since.
  • Beaconlight Capital's Elevance Health position peaked at $13M in Q2 2018.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Beaconlight Capital's 13F filing for Q2 2026, filed 14 Aug 2026.